White Papers by Sherpa Clinical Packaging

  • Sherpa Guide EU Annex 13 Labeling

    The purpose of this guide is to walk US-based clinical supply professionals through the labeling requirements laid out in Annex 13 of the EU GMP guidelines. This annex details guidance for Investigational Medicinal Products (IMPs), and this handbook will focus only on those Articles applicable...
  • 6 Strategies To Stretch Your Limited Drug Supply For Clinical Studies

    A clinical packaging strategy that can successfully manage the supply of your expensive drug product throughout the duration of clinical testing is critical to the success of sponsor companies. This paper explores six strategies that can be used to maximize a short drug supply for your...